17-09-2012
European patient organisations concerned about CVZ advice regarding Pompe and Fabry
European patient organisations concerned about CVZ advice regarding Pompe and Fabry Read more >>
22-07-2012
Gene therapy: EGAN protests against rejection of marketing authorization for Glibera
On the 20th of July, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended marketing authorization of Glybera, for the treatment of lipoprotein lipase ... Read more >>
17-04-2012
EGAN signs MoU with ENHA and EPF
Following the call to action (European Innovation Partnership on Active and Healthy Ageing, 3 April 2012, Brussels), EGAN has signed the Memorandum of Understanding. Read more >>
28-03-2012
Successfull launch EUPATI
The European Patients' Academy on Therapeutic Innovation (EUPATI) was successfully launched on 27 March 2012 during the DIA EuroMeeting in Copenhagen. Read more >>
11-10-2011
EMA makes paediatric study data public
The EMA has launched a new database with information on medicine studies carried out in children until 2007. Read more >>